Science news articles about 'glitazones'

... type 2 diabetes experience hypoglycaemic events less frequently if they use metformin and a glitazone than if they use a combination of metformin and a sulfonylurea (with comparable lowering of blood- ...

... were prescribed at 54 percent and 28 percent of treatment visits, respectively The increasing use of glitazones—along with other new treatments, including new forms of insulin and other new classes ...

... drugs and of insulin treatment, giving preference to insulin-sensitizers such as metformin and glitazones. Because diabetes may be secondary to HCC or to the underlying cirrhosis, and the liver ...

... taking pioglitazone (Actos). Other studies have linked rosiglitazone (Avandia)—the only other approved glitazone drug—to a possible increase in the risk of myocardial infarction. Although the study ...

Patients taking glitazones at increased risk of diabetic macular edema, suggests a new study.

... at first, but many people eventually need to take tablets. Rosiglitazone belongs to a group of drugs called glitazones, which became available in 2000. Like other glitazones, it tends to be used once ...

... suggests that giving patients anti-inflammatory and immunomodulatory agents such as statins, fibrates and glitazones could help to regulate the cell signalling pathways in patients who have suffered ...

... . No trials were found even for well-established antidiabetics such as insulin or glitazones. It was only possible to compare glinides with metformin and sulfonylureas. Neither benefit nor harm could ...